Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral propranolol (Deralin) for early-stage retinopathy of prematurity
MOH_2017-11-08_001906Phase 2Not yet recruiting
- Sponsor
- פרופ' בני בר-עוז
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in retinopathy of prematurity (ROP) comparing Deralin plus standard care with Placebo plus standard care (2 arms). Planned start Jun 2017; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on MOH_2017-11-08_001906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-11-08_001906.